Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The flu vaccine in powder form – the answer to a pandemic?

21.12.2007
In recent years, the bird flu virus has caught the attention of all of Western Europe. In 2006 in particular, there was a lot of speculation about a wide-scale flu outbreak, in other words a pandemic. The Dutch government was worried about running short of vaccine, mainly because it has a very short shelf-life.

All that could change, says PhD student Jean-Pierre Amorij of the University of Groningen. In his thesis he describes a way of storing flu vaccine in powder form. It can then be stored for at least a year – more than enough time to build up national stocks.

Amorij will be awarded his PhD on 4 January 2008. During the past four years he has examined all kinds of methods for long-term storage of the flu vaccine. The answer lay in what is known as freeze drying – a protein molecule, such as a vaccine, is extremely quickly frozen between millions of sugar molecules. These molecules bunch together like miniscule balls around the vaccine, so that it can be stored stably in a dried form.

Sugars
Amorij did not use ordinary sugars for the freeze-drying process but special types like inulin and trehalose. It took Amorij eighteen months to find a freeze-drying process that was exactly right. That is painstaking but important work because the vaccine still has to work even after freeze drying. ‘The biggest problem was choosing the right freezing speed and the right sugar', says Amorij. But he managed it. The result looks like icing sugar.
No need for a flu jab
Freeze-dried flu vaccine not only has a longer shelf-life, it’s also easier to use. You don’t need injection needles any more as the powdered vaccine can be swallowed or inhaled. That will save a lot of time if the government has to vaccinate a lot of people very fast during a pandemic. You don’t need medical personnel to be present when swallowing or inhaling. Amorij also conducted tests on mice to see whether inhaling or swallowing worked best. ‘Inhaling was by far the most effective with the mice,’ he says. ‘The immune reaction was even more powerful than with an injection.’ According to Amorij, the powder is particularly suited to inhalation. It is very light and stays suspended so it can penetrate deep into the lungs. That makes absorption even more efficient.
Application
When the time comes, it thus looks as if all of the Netherlands will be immunised during a pandemic via inhalers. However, according to Amorij the application will take some time yet. ‘So far we’ve only tested it on mice. The tests on people still have to take place. If everything goes well, then that could happen within five years. If there are a few setbacks it could take ten years. One thing is certain, though, it’s on its way.’
Curriculum Vitae
Jean-Pierre Amorij (Zaanstad, 1978) studied Pharmacy and Pharmaceutical Engineering at the University of Groningen and was awarded his Pharmacist’s diploma in 2003. His PhD thesis at the Faculty of Mathematics and Natural Sciences of the University of Groningen was supervised by Prof. H.W. Frijlink. He conducted his research at the Department of Pharmaceutical Engineering and Biopharmaceutics of the University of Groningen in close cooperation with the Department of Medical Microbiology, Molecular Virology section (Prof. J.C. Wilschut) of the University Medical Center Groningen and the University of Groningen. His thesis is entitled The Development Of Stable Influenza Vaccine Powder Formulations For New Needle Free Dosage Forms.

Jos Speekman | alfa
Further information:
http://www.rug.nl/Corporate/nieuws/archief/archief2007/persberichten/133_07

Further reports about: Amorij Vaccine flu pandemic

More articles from Life Sciences:

nachricht Superresolution live-cell imaging provides unexpected insights into the dynamic structure of mitochondria
18.02.2020 | Heinrich-Heine-Universität Düsseldorf

nachricht Blood and sweat: Wearable medical sensors will get major sensitivity boost
18.02.2020 | Moscow Institute of Physics and Technology

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Freiburg researcher investigate the origins of surface texture

Most natural and artificial surfaces are rough: metals and even glasses that appear smooth to the naked eye can look like jagged mountain ranges under the microscope. There is currently no uniform theory about the origin of this roughness despite it being observed on all scales, from the atomic to the tectonic. Scientists suspect that the rough surface is formed by irreversible plastic deformation that occurs in many processes of mechanical machining of components such as milling.

Prof. Dr. Lars Pastewka from the Simulation group at the Department of Microsystems Engineering at the University of Freiburg and his team have simulated such...

Im Focus: Skyrmions like it hot: Spin structures are controllable even at high temperatures

Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices

The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...

Im Focus: Making the internet more energy efficient through systemic optimization

Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.

Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.

Im Focus: New synthesis methods enhance 3D chemical space for drug discovery

After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.

"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.

Im Focus: Quantum fluctuations sustain the record superconductor

Superconductivity approaching room temperature may be possible in hydrogen-rich compounds at much lower pressures than previously expected

Reaching room-temperature superconductivity is one of the biggest dreams in physics. Its discovery would bring a technological revolution by providing...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

70th Lindau Nobel Laureate Meeting: Around 70 Laureates set to meet with young scientists from approx. 100 countries

12.02.2020 | Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

 
Latest News

Movement of a liquid droplet generates over 5 volts of electricity

18.02.2020 | Power and Electrical Engineering

Powering the future: Smallest all-digital circuit opens doors to 5 nm next-gen semiconductor

18.02.2020 | Information Technology

Studying electrons, bridging two realms of physics: connecting solids and soft matter

18.02.2020 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>